ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.
Joshi J Alumkal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.